Summer Pharmacy Happenings!

Summer has brought in some changes in the pharmacy realm offering us additional potential to mitigate claims! The lowest Average Wholesale Price has been impacted by drugs which went generic, seen price drops and newly available to the market.  Drugs that went generic: Duexis® (ibuprofen/famotidine) 800mg-26.6mg tablet – $33.09 to $11.08 for the generic; 66.5%… Read more »

Dangers of Combining Opioids and Benzodiazepines

Opioids are not the only prescription drugs fueling injured worker’s addiction, risk of overdose deaths as well as cost of therapy. Extreme dangers are associated with combined use of benzodiazepines and opioids.

Price Slash on a Commonly Seen MSA Drug — Omeprazole

Well, for those of us who developed an ulcer or have one in the works, either from this past year or the high Part D cost, here is some good news! Omeprazole, in the 40mg prescription strength, has seen a significant slash in the lowest average wholesale price (AWP) – see Table 1. Table 1… Read more »

Sertraline (Zoloft®) Price Cut

With the start of a new year, we typically see price hikes but that is not the case with sertraline (Zoloft®) where we have seen a significant price cut. Sertraline, a selective serotonin reuptake inhibitor (SSRI), is FDA approved for major depressive disorder (MDD), obsessive-compulsive disorder, panic disorder, post-traumatic stress disorder (PTSD), premenstrual dysphoric disorder… Read more »

Another Price Drop for Celecoxib (Celebrex®)

Celecoxib (Celebrex®), the only available cyclooxygenase-2a (COX-2) in the United States, has had a price drop this month in the 200mg capsule formulation. Celecoxib is FDA indicated to treat signs and symptoms of osteoarthritis, rheumatoid arthritis, juvenile rheumatoid arthritis and ankylosing spondylitis. It is also indicated to manage acute pain and to treat primary dysmenorrhea.… Read more »

Aripiprazole (Abilify®) Price Drop

Abilify® (aripiprazole), a second generation atypical antipsychotic, has been a high cost medication until a recent and dramatic reduction in price. Aripiprazole is FDA approved for schizophrenia and acute mania, and as an adjunct second-line therapy for bipolar maintenance and major depressive disorder. It also has non-FDA medically accepted uses of borderline personality disorder and… Read more »

Falling Oxycodone Prices and FDA Requirement for Labeling Changes

We continue to have falling opioid prices with the latest being the oxycodone formulations. While opioid volume and costs are on a downward trend in utilization, per current drug trends reports, they remain the highest in the top 10 prescribed drugs in the workers’ compensation realm, by spend and utilization. Nearly 25% of injured workers… Read more »